Case-case-control study of risk factors for nasopharyngeal colonization with methicillin-resistant Staphylococcus aureus in a medical-surgical intensive care unit

Brazilian Journal of Infectious Diseases

Volumn 13, Issue 6, 2009, Pages 398-402

  de Melo, Edson Carvalho ^a   Fortaleza, Carlos Magno Castelo Branco ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Intensive care unit; Methicillin resistant Staphylococcus aureus; Nasopharyngeal colonization

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFALOTIN; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HOSPITAL BASED CASE CONTROL STUDY; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INTENSIVE CARE; LENGTH OF STAY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NASOPHARYNX; NONHUMAN; STAPHYLOCOCCUS AUREUS; AGED; CASE CONTROL STUDY; DRUG EFFECT; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; STAPHYLOCOCCUS INFECTION;

AGED; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NASOPHARYNX; RETROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS;

EID: 77953939934     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1413-86702009000600002     Document Type: Article

References (19)

1. Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis. 2001; 7: 178-182.
2. Klevens RM, Edwards JR, Tenover FC et al. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis. 2006 42: 389-391.
3. Gastmeier P, Sohr D, Geffers C et al. Mortality risk factors with nosocomial Staphylococcus aureus infections in intensive care units: results from the German Nosocomial Infection Surveillance System (KISS). Infection. 2005; 33:50-55.
4. Kopp BJ, Nix DE, Armstrong EP. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections. Ann Pharmacother. 2004; 38:1377-1382.
5. Jarvis WR. The epidemiology of colonization. Infect Control Hosp Epidemiol. 1996; 17: 47-52.
6. Muto CA, Jernigan JA, Ostrowsky B et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol. 2003; 24: 362-386.
7. Calfee DP, Salgado CD, Classen D et al. Strategies to prevent transmission of Methicillin-Resistant Staphylococcus aureus in acute care hospitals. Infect Control Hosp Epidemiol. 2008; 29 (suppl.): S62-S80.
8. Harris AD, Karchmer TB, Carmeli Y, Samore MH. Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. Clin Infect Dis. 2001; 32: 1055-1061.
9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests; approved standard, 8th ed. Pennsylvania: CLSI; 2003.
10. Kaye KS, Harris AD, Samore M, Carmeli Y. The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistance. Infect Control Hosp Epidemiol. 2005; 26:346-351.
11. World Health Organization. International Classification of Diseases. 10th revision, 2005 update. Geneva, Switzerland: WHO; 2005.
12. Knaus WA, Draper EA, Wagner DR, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985; 13: 818-829.
13. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989; 79: 340-349.
14. Siegel JD, Rhinehart E, Jackson M et al. Management of multidrugresistant organisms in health care settings, 2006. Am J Infect Control. 2007; 35 (10 Suppl 2): S165-S193.
15. Marshall C, Harrington G, Wolfe R, Fairley CK, Wesselingh S, Spelman D. Acquisition of Methicillin-resistant Staphylococcus aureus in a large intensive care unit. Infect Control Hosp Epidemiol. 2003; 24: 322-326.
16. Oztoprak N, Cevik MA, Akinci E, Korkmaz M, Erbay A, Eren SS et al. Risk factors for ICU-acquired Methicillin-resistant Staphylococcus aureus infections. Am J Infect Control. 2006; 34:1- 5.
17. Weber SG, Gold HS, Hooper DC, Karchmer AW, Carmeli Y. Fluoroquinolones and the risk for Methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis. 2003; 9:1415-1422.
18. Bisognano C, Vaudaux P, Rohner P, Lew DP, Hooper DC. Induction of fibronectin-binding proteins and increased adhesion of Quinolone-resistant Staphylococcus aureus by subinhibitory levels of Ciprofloxacin. Antimicrob Agents Chemother. 2000; 44: 1428-1437.
19. Hardy KJ, Hawkey PM, Gao F, Oppenheim BA. Methicillin resistant Staphylococcus aureus in the critically ill. Br J Anaesth. 2004; 92: 121-130.